1. Home
  2. Analysis
  3. Lamictal
  4. Normochromic-normocytic-anaemia

Lamictal and Normochromic normocytic anaemia - a phase IV clinical study of FDA data

Summary:

Normochromic normocytic anaemia is reported as a side effect among people who take Lamictal (lamotrigine), especially for people who are female, 20-29 old, have been taking the drug for 1 - 6 months also take Folic Acid, and have Depression.

The phase IV clinical study analyzes which people have Normochromic normocytic anaemia when taking Lamictal. It is created by eHealthMe based on reports of 74,218 people who have side effects when taking Lamictal from the FDA, and is updated regularly.

What is Lamictal?

Lamictal has active ingredients of lamotrigine. It is often used in bipolar disorder. eHealthMe is studying from 82,629 Lamictal users. Check the latest studies of Lamictal.

What is Normochromic normocytic anaemia?

Normochromic normocytic anaemia (forms of anaemia in which the average size and haemoglobin content of the red blood cells are within normal limits) is found to be associated with 526 drugs and 712 conditions by eHealthMe. Check the latest studies of Normochromic normocytic anaemia.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

74,218 people reported to have side effects when taking Lamictal.
Among them, 45 people (0.06%) have Normochromic normocytic anaemia.

Could Lamictal cause Normochromic normocytic anaemia?

Among these 45 people:

How long have people been on Lamictal when they have Normochromic normocytic anaemia? *

  • < 1 month: 40.0 %
  • 1 - 6 months: 53.33 %
  • 6 - 12 months: 6.67 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Normochromic normocytic anaemia when taking Lamictal? *

  • female: 67.44 %
  • male: 32.56 %

What is the age of people who have Normochromic normocytic anaemia when taking Lamictal? *

  • 0-1: 0.0 %
  • 2-9: 2.63 %
  • 10-19: 5.26 %
  • 20-29: 28.95 %
  • 30-39: 10.53 %
  • 40-49: 7.89 %
  • 50-59: 18.42 %
  • 60+: 26.32 %

What are other drugs people take besides Lamictal? *

  1. Folic Acid: 7 people, 15.56%
  2. Alesse: 6 people, 13.33%
  3. Lorazepam: 4 people, 8.89%
  4. Ativan: 4 people, 8.89%
  5. Lovenox: 4 people, 8.89%
  6. Lasix: 4 people, 8.89%
  7. Keppra: 4 people, 8.89%
  8. Nexium: 4 people, 8.89%
  9. Valproic Acid: 4 people, 8.89%
  10. Valproate Sodium: 3 people, 6.67%

What are other side effects people have besides Normochromic normocytic anaemia? *

  1. Leukopenia (less number of white blood cells in blood): 13 people, 28.89%
  2. Fever: 13 people, 28.89%
  3. Weakness: 8 people, 17.78%
  4. Foot Fracture: 8 people, 17.78%
  5. Thrombocytopenia (decrease of platelets in blood): 7 people, 15.56%
  6. Thrombocythaemia (an increased number of platelets in the circulating blood): 7 people, 15.56%
  7. Femoral Neck Fracture (neck of femur bone fracture): 7 people, 15.56%
  8. Rash Maculo-Papular (red area on the skin that is covered with small confluent bumps): 7 people, 15.56%
  9. Osteomalacia (softening of the bones due to a lack of vitamin d): 6 people, 13.33%
  10. Bone Pain: 6 people, 13.33%

What are the existing conditions these people have? *

  1. Depression: 9 people, 20.00%
  2. High Blood Pressure: 5 people, 11.11%
  3. Rash Maculo-Papular (red area on the skin that is covered with small confluent bumps): 4 people, 8.89%
  4. Insomnia (sleeplessness): 3 people, 6.67%
  5. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 3 people, 6.67%
  6. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 3 people, 6.67%
  7. Lennox-Gastaut Syndrome (epilepsy characterized by frequent seizures and different seizure types): 2 people, 4.44%
  8. Cardiomyopathy (weakening of the heart muscle): 2 people, 4.44%
  9. Headache (pain in head): 2 people, 4.44%
  10. Stress And Anxiety: 2 people, 4.44%

* Approximation only. Some reports may have incomplete information.

Do you take Lamictal and have Normochromic normocytic anaemia?

- Check whether Normochromic normocytic anaemia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Lamictal:

Normochromic normocytic anaemia treatments and more:

How severe was Normochromic normocytic anaemia and when was it recovered:

Expand to all the drugs that have ingredients of lamotrigine:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Lamictal:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Normochromic normocytic anaemia:

Browse all the conditions that are associated with Normochromic normocytic anaemia:

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on lamotrigine (the active ingredients of Lamictal) and Lamictal (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.